Kimryn Rathmell | |
---|---|
17th Director of the National Cancer Institute | |
Assumed office December 18, 2023 | |
President | Joe Biden |
Preceded by | Monica Bertagnolli |
Personal details | |
Born | Wendy Kimryn Meyer November 3,1969 Omaha,Nebraska,U.S. |
Spouse | Jeffrey Rathmell |
Education | University of Northern Iowa (BA,BS) Stanford University (MS,PhD,MD) Vanderbilt University (MS) |
W. Kimryn Rathmell (born November 3,1969) is an American physician-scientist whose work focuses on the research and treatment of patients with kidney cancers. She is the Director of the National Cancer Institute,and most recently served the Hugh Jackson Morgan Professor and Chair of the Department of Medicine at Vanderbilt University Medical Center (VUMC),and Physician-in-Chief for Vanderbilt University Adult Hospital and Clinics in Nashville,Tennessee. [1] On November 17,2023,Rathmell was nominated by President Biden as the next Director of the National Cancer Institute. [2]
In 1991,Rathmell graduated from the University of Northern Iowa with a Bachelor of Science (BS) in Biology and a Bachelor of Arts (BA) in Chemistry. She subsequently earned a Doctor of Philosophy (PhD) in Biophysics in 1996 under the mentorship of Gilbert Chu,and a Doctor of Medicine (MD) in 1998 from Stanford University. [3] The title of her PhD thesis was "Ku and DNA/PK in the repair of DNA double strand breaks." Following completion of her MD,Rathmell did an Internal Medicine internship at the University of Chicago before attending the University of Pennsylvania where she completed her Internal Medicine residency and Medical Oncology fellowship training. Rathmell completed additional postdoctoral training at the University of Pennsylvania under the mentorship of M. Celeste Simon,PhD,and at the University of North Carolina at Chapel Hill (UNC) under the mentorship of Terry Van Dyke,PhD. [4] In 2022,she completed a Master of Management in Health Care at the Owen School of Management at Vanderbilt University.
In 2003,Rathmell joined faculty at UNC where she held primary and secondary appointments in the departments of Medicine and Genetics. While there,she served as Co-Director of the Howard Hughes Medical Institute Graduate Training Program in Translational Medicine, [5] Associate Director for Training and Education at UNC Lineberger Comprehensive Cancer Center,and Associate Director of the Medical Scientist Training Program.
In 2015,she joined VUMC as Professor of Medicine and Director of the Division of Hematology and Oncology, [6] with secondary appointments in the departments of Cancer Biology and Biochemistry. Rathmell was successively named Cornelius Abernathy Craig Professor of Medicine. [7] In 2019,she was named Deputy Director for Research Integration and Career Development at Vanderbilt-Ingram Cancer Center. She served in this role until her current appointment as the Hugh Jackson Morgan Professor and Chair of the Department of Medicine and Physician-in-Chief for Vanderbilt University Adult Hospital and Clinics in 2020. [8] She is the second woman to serve as Chair of the Department of Medicine at VUMC,and immediately succeeds Nancy J. Brown.
Rathmell has been actively involved in research related to the genetics and molecular biology of complex renal cancers. A member of The Cancer Genome Atlas (TCGA),her research has resulted in more than 200 articles in leading peer-reviewed journals,including The New England Journal of Medicine ,Nature,and the Journal of Clinical Investigation . [9]
Prior to her appointment as Director,Rathmell served on the National Cancer Institute's Board of Scientific Advisors, [10] the Keystone Symposia's Board of Directors [11] and the Forbeck Foundation Scientific Board of Directors. She is a former associate editor for the Journal of Clinical Investigation,and recently[ when? ] served as senior editor for eLife . She has previously held leadership roles for the American Society of Clinical Oncology,the Department of Defense Congressionally Directed Medical Research Program (Kidney Cancer Research Program),and the American Society for Clinical Investigation [12] (ASCI),in which she served as secretary-treasurer and society President in 2019-2020. [13]
Rathmell is a 2023 recipient of the Doris Duke Foundation's Paragon Award. [14] She received the 2020 American Association for Cancer Research Team Science Award for TCGA, [15] and the 2019 Eugene P. Schonfeld Award for Outstanding Contributions in Kidney Cancer from the Kidney Cancer Association. [16] Rathmell has been elected to the ASCI, [13] the Association of American Physicians,and as fellow of the American Association for the Advancement of Science. [17]
In recognition of her contributions to kidney cancer research and the advancement of the physician-scientist career path,she was elected to the National Academy of Medicine, [18] and in 2023,she was elected to the American Academy of Arts and Sciences. [19] On December 18,2023 she assumed her role as the Director of the National Cancer Institute.
Rathmell resides in Nashville with her husband,Jeffrey Rathmell,a professor at VUMC and director for the Vanderbilt Center for Immunobiology. [20] They have two children.
The Vanderbilt University Medical Center (VUMC) is a medical provider with multiple hospitals in Nashville,Tennessee,as well as clinics and facilities throughout Middle Tennessee. VUMC is an independent non-profit organization,but maintains academic affiliations with Vanderbilt University. As of 2023,the health system had more than 3 million patient visits a year,a workforce of 40,000,and 1,741 licensed hospital beds.
The Medical Scientist Training Programs (MSTPs) are dual-degree training programs that streamline the education towards both clinical and research doctoral degrees. MSTPs are offered by some United States medical schools,who are awarded financial support from the National Institute of General Medical Sciences,a branch of the National Institutes of Health (NIH). The goal of these training programs is to produce physician scientists who can translate laboratory discoveries into effective treatments for patients.
The Doctorate of Medicine and of Philosophy (MD–PhD) is a dual doctoral degree for physician–scientists,combining the professional training of the Doctor of Medicine degree with the research expertise of the Doctor of Philosophy degree;the Ph.D. is the most advanced credential in the United States. Other dual degree programs exist,such as the joint MD–JD degree;both the JD professional degree and the MD are not universally recognized internationally,however. The National Institutes of Health currently provides 50 medical schools with Medical Scientist Training Program grants that support the training of students in MD–PhD programs at these institutions through tuition and stipend allowances. These programs are often competitive,with some admitting as few as two students per academic year. The MCAT score and GPA of MD–PhD matriculants are often higher than MD only matriculants.
Vanderbilt University School of Medicine (VUSM) is the graduate medical school of Vanderbilt University,a private research university located in Nashville,Tennessee. The School of Medicine is primarily housed within the Eskind Biomedical Library which sits at the intersection of the Vanderbilt University and Vanderbilt University Medical Center (VUMC) campuses and claims several Nobel laureates in the field of medicine. Through the Vanderbilt Health Affiliated Network,VUSM is affiliated with over 60 hospitals and 5,000 clinicians across Tennessee and five neighboring states which manage more than 2 million patient visits each year. As the home hospital of the medical school,VUMC is considered one of the largest academic medical centers in the United States and is the primary resource for specialty and primary care in hundreds of adult and pediatric specialties for patients throughout the Mid-South.
The Society for Immunotherapy of Cancer (SITC),previously known as the International Society for Biological Therapy of Cancer (iSBTc),is a professional society of scientists,academicians,researchers,clinicians,government representatives,and industry leaders from around the world dedicated to improving outcomes in patients with cancer by advancing the science and application of cancer immunotherapy. Currently,SITC has more than 2,400 members,representing 22 medical specialties from 42 countries around the world,who are engaged in the research and treatment of cancer.
Olufunmilayo I. Olopade born in the year 1957,is a Nigerian hematology oncologist,Associate Dean for Global Health and Walter L. Palmer,Distinguished Service Professor in Medicine and Human Genetics at the University of Chicago. She also serves as director of the University of Chicago Hospital's Cancer Risk Clinic.
Consuelo H. Wilkins is an American physician,biomedical researcher,and health equity expert. She is Senior Vice President and Senior Associate Dean for Health Equity and Inclusive Excellence at Vanderbilt University Medical Center. She is a professor of medicine in the Department of Medicine,Division of Geriatrics at Vanderbilt University School of Medicine and has a joint appointment at Meharry Medical College. She additionally serves as one of the principal investigators of the Vanderbilt Clinical and Translational Science Award,Director of the Meharry-Vanderbilt Community Engaged Research Core (CTSA) and as vice president for Health Equity at Vanderbilt University Medical Center.
Norman Edward "Ned" Sharpless is the previous Director of the National Cancer Institute (NCI). Before that,Sharpless was Professor of Medicine and Genetics Chair,Director of University of North Carolina UNC Lineberger Comprehensive Cancer Center,Molecular Therapeutics,Wellcome Distinguished Professorship in Cancer Research.
Charis Eng is a Singapore-born physician-scientist and geneticist at the Cleveland Clinic,notable for identifying the PTEN gene. She is the Chairwoman and founding Director of the Genomic Medicine Institute of the Cleveland Clinic,founding Director and attending clinical cancer geneticist of the institute’s clinical component,the Center for Personalized Genetic Healthcare,and Professor and Vice Chairwoman of the Department of Genetics and Genome Sciences at Case Western Reserve University School of Medicine.
Lisa A. Carey is a Distinguished Professor in Breast Cancer Research at UNC School of Medicine,Division Chief of Hematology and Oncology,and physician-in-chief of the N.C. Cancer Hospital,UNC Lineberger's clinical home. She studied at the Johns Hopkins School of Public Health,and was named co-chair of the Alliance National Cooperative Group Breast Committee in 2016.
Christine M. Lovly is an associate professor of medicine at Vanderbilt University. Her research involves the development of novel treatment strategies for ALK positive lung cancer.
Wendy Rosamund Brewster was a British-born American gynaecologist who was Professor of Obstetrics and Gynaecology and Director of the Center for Women's Health Research at the University of North Carolina at Chapel Hill.
Nancy J. Brown is an American physician-scientist. She is the Jean and David W. Wallace Dean and C.N.H. Long Professor of Internal Medicine at Yale University School of Medicine,having formerly served as the Hugh Jackson Morgan Professor of Medicine and Pharmacology,and Chair and Physician-in-Chief of the Department of Medicine at Vanderbilt University School of Medicine.
David "Neil" Hayes is an American oncologist and physician–scientist. He is the Van Vleet Endowed Professor in Medical Oncology and the division chief of haematology and oncology at the University of Tennessee Health Science Center. As a result of his research,Hayes was elected a Member of the American Society for Clinical Investigation.
Barney S. Graham is an American immunologist,virologist,and clinical trials physician.
Levi A. Garraway is an American oncologist. His research team was among the first to adapt genomics technologies to enable scalable,high-throughput clinical approaches to cancer gene mutation profiling. As a result,he was inducted into the American Society for Clinical Investigation,American Association for Cancer Research,and National Academy of Medicine.
Karen Marie Winkfield is an American radiation oncologist,physician-scientist,and implementation scientist. She is the Ingram Professor of Cancer Research at Vanderbilt University School of Medicine.
Mary Lou McMaster is an American oncologist and clinical trialist who researches familial cancer genetics. She is a senior clinical trial specialist at the National Cancer Institute and a captain in the United States Public Health Service Commissioned Corps.
Ambra A. Pozzi is an Italian American physician who is a professor of nephrology in the Vanderbilt University Medical Center. She works on matrix biology and matrix receptor biology. In 2022,she was appointed President Elect of the American Society for Matrix Biology.
Allison Beck McCoy is an American biomedical informatician focused on clinical informatics/health informatics. She is an associate professor of biomedical informatics and director of the clinical informatics core at the Vanderbilt University School of Medicine. She was elected a fellow of the American Medical Informatics Association and American College of Medical Informatics in 2018 and 2023 respectively.